Pentraxins and atherosclerosis

QR Code

Pentraxins and atherosclerosis

© 2012 Springer-Verlag/Wien. All rights are reserved. Pentraxins are a family of evolutionarily conserved multifunctional patternrecognition proteins characterized by a cyclic multimeric structure. Based on the primary structure of the subunit, the pentraxins are divided into two groups: short pentr...

Full description

Bibliographic Details
Main Authors:	Barbati, E., Bottazzi, B., Catapano, A., Garlanda, C., Latini, R., Mantovani, A., Norata, Giuseppe, Valentino, S.
Format:	Book Chapter
Published:	2014
Online Access:	http://hdl.handle.net/20.500.11937/56176

Similar Items

Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation
by: Bonacina, F., et al.
Published: (2016)

Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)

Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population
by: Baragetti, A., et al.
Published: (2014)

HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)

LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)

Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)

Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction a biological rheostat for fibroblast growth factor 2-mediated angiogenesis
by: Leali, D., et al.
Published: (2012)

High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)

The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)

Long pentraxin PTX3 as a prognostic marker of cardiovascular mortality in patients with chronic kidney disease
by: Baragetti, A., et al.
Published: (2017)

MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
by: Norata, Giuseppe, et al.
Published: (2013)

Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
by: Ruscica, M., et al.
Published: (2017)

Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse
by: Norata, Giuseppe, et al.
Published: (2012)

Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population
by: Baragetti, A., et al.
Published: (2016)

IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population
by: Dhyani, A., et al.
Published: (2015)

Genetically determined telomeres shortening is associated with carotid atherosclerosis progression and increased incidence of cardiovascular events
by: Baragetti, A., et al.
Published: (2016)

Antigen-dependent and antigen-independent pathways modulate CD4 +CD28 null T-cells during atherosclerosis
by: Ammirati, E., et al.
Published: (2012)

MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice
by: Sala, F., et al.
Published: (2014)

Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis
by: Ammirati, E., et al.
Published: (2015)

Effector memory T cells are associated with atherosclerosis in humans and animal models
by: Ammirati, E., et al.
Published: (2012)

An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode
by: Doni, A., et al.
Published: (2015)

Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)

HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)

The predictive and diagnostic accuracy of vascular endothelial growth factor and pentraxin-3 in severe dengue
by: Kim, Gary Kuan Low, et al.
Published: (2018)

The Predictive And Diagnostic Accuracy Of Pentraxin-3 And Vascular Endothelial Growth Factor In Severe Dengue
by: Low, Gary Kim Kuan
Published: (2019)

New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs
by: Norata, Giuseppe, et al.
Published: (2013)

Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment
by: Garetto, S., et al.
Published: (2015)

Disease trends over time and CD4+CCR5+ T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus
by: Baragetti, A., et al.
Published: (2017)

Postprandial lipemia as a cardiometabolic risk factor
by: Pirillo, A., et al.
Published: (2014)

Novel concepts in HDL pharmacology
by: Remaley, A., et al.
Published: (2014)

High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)

Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)

HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)

Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7urs8qmkfimvoiiehafmpmjjkk